AtaiBeckley (ATAI) Soars to 4-Year High on $3.8B Merger with Eli Lilly
July 17, 2026 · 5 sources · High impact · Updated Jul 21, 2026
AtaiBeckley (ATAI) has been acquired by Eli Lilly (LLY) for up to $3.8 billion, leading to a significant surge in ATAI's stock price to a four-year high. This acquisition highlights a growing interest from large pharmaceutical companies in psychedelic-based therapies, although some analysts have downgraded ATAI due to capped near-term upside post-buyout.
Affected Companies
LLY57 ▼3
ELI LILLY & Co$1,179.11$1.11T cap
ATAI72 ▼4
AtaiBeckley Inc.$7.22$2.66B cap
ASTS76 ▲5
AST SpaceMobile, Inc.$57.42$29.07B cap
USB58 ▼3
US BANCORP DE$63.14$98.01B cap
CFG75 ▲22
CITIZENS FINANCIAL GROUP INC/RI$71.50$30.24B cap
PANW64 ▼2
Palo Alto Networks Inc$348.66$284.16B cap
TRV84 ▲3
TRAVELERS COMPANIES, INC.$368.50$76.86B cap
Affected Industries
AlphaOS aggregates and analyzes market news to extract structured investment intelligence. Content is for research and education only — not investment advice.